Shimizu Yusuke, Ntege Edward Hosea, Sunami Hiroshi, Inoue Yoshikazu
Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Nakagami, Okinawa, 903-0215, Japan.
Center for Advanced Medical Research, School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Nakagami, Okinawa, 903-0215, Japan.
Regen Ther. 2022 Oct 31;21:527-539. doi: 10.1016/j.reth.2022.10.005. eCollection 2022 Dec.
Hair loss, or alopecia, is associated with several psychosocial and medical comorbidities, and it remains an economic burden to individuals and the society. Alopecia is attributable to varied mechanisms and features a multifactorial predisposition, and the available conventional medical interventions have several limitations. Thus, several therapeutic strategies for alopecia in regenerative medicine are currently being explored, with increasing evidence suggesting that mesenchymal stem cell (MSC) implantation, MSC-derived secretome treatment, and blood-derived platelet-rich plasma therapies are potential treatment options. In this review, we searched the Cochrane Library, MEDLINE (PubMed), EMBASE, and Scopus using various combinations of terms, such as "stem cell," "alopecia," "hair loss," "Androgenetic alopecia," "male-pattern hair loss," "female-pattern hair loss," "regenerative hair growth," "cell therapy," "mesenchymal stem cells," "MSC-derived extracellular vesicles," "MSC-derived exosomes," and "platelet-rich plasma" and summarized the most promising regenerative treatments for alopecia. Moreover, further opportunities of improving efficacy and innovative strategies for promoting clinical application were discussed.
脱发,即秃发,与多种心理社会和医学合并症相关,并且仍然是个人和社会的经济负担。秃发归因于多种机制,具有多因素易感性,现有的传统医学干预措施存在若干局限性。因此,目前正在探索再生医学中治疗秃发的几种治疗策略,越来越多的证据表明间充质干细胞(MSC)植入、MSC衍生的分泌组治疗和血液来源的富血小板血浆疗法是潜在的治疗选择。在本综述中,我们使用各种术语组合在考克兰图书馆、MEDLINE(PubMed)、EMBASE和Scopus中进行检索,如“干细胞”、“秃发”、“脱发” “雄激素性秃发”、“男性型脱发”、“女性型脱发”、“再生性毛发生长”、“细胞疗法”、“间充质干细胞”、“MSC衍生的细胞外囊泡”、“MSC衍生的外泌体”和“富血小板血浆”,并总结了最有前景的秃发再生治疗方法。此外,还讨论了提高疗效的进一步机会以及促进临床应用的创新策略。